These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
106 related articles for article (PubMed ID: 11078404)
1. Endothelin-A-receptor blockade improves renal function and doubles the lifespan of stroke-prone spontaneously hypertensive rats. Touyz RM; Turgeon A; Schiffrin EL J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S300-4. PubMed ID: 11078404 [TBL] [Abstract][Full Text] [Related]
2. Endothelin A receptor blockade decreases expression of growth factors and collagen and improves matrix metalloproteinase-2 activity in kidneys from stroke-prone spontaneously hypertensive rats. Tostes RC; Touyz RM; He G; Ammarguellat F; Schiffrin EL J Cardiovasc Pharmacol; 2002 Jun; 39(6):892-900. PubMed ID: 12021584 [TBL] [Abstract][Full Text] [Related]
3. Effect of chronic ETA-selective endothelin receptor antagonism on blood pressure in experimental and genetic hypertension in rats. Schiffrin EL; Turgeon A; Deng LY Br J Pharmacol; 1997 Jul; 121(5):935-40. PubMed ID: 9222550 [TBL] [Abstract][Full Text] [Related]
4. A role for endothelin ETA receptors in regulation of renal function in spontaneously hypertensive rats. Bird JE; Webb ML; Giancarli MR; Chao C; Dorso CR; Asaad MM Eur J Pharmacol; 1995 Dec; 294(1):183-9. PubMed ID: 8788430 [TBL] [Abstract][Full Text] [Related]
5. Endothelin-A receptor antagonist combined with hydralazine improves survival and renal function in hypertensive rats. Münter K; Hergenröder S; Kirchengast M J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S245-8. PubMed ID: 9595450 [TBL] [Abstract][Full Text] [Related]
6. Early-onset but not late-onset endothelin-A-receptor blockade can modulate hypertension, cerebral edema, and proteinuria in stroke-prone hypertensive rats. Blezer EL; Nicolay K; Goldschmeding R; Jansen GH; Koomans HA; Rabelink TJ; Joles JA Hypertension; 1999 Jan; 33(1):137-44. PubMed ID: 9931094 [TBL] [Abstract][Full Text] [Related]
7. ET(A) receptor antagonist prevents blood pressure elevation and vascular remodeling in aldosterone-infused rats. Park JB; Schiffrin EL Hypertension; 2001 Jun; 37(6):1444-9. PubMed ID: 11408393 [TBL] [Abstract][Full Text] [Related]
8. Endothelin receptor A blockade reduces proteinuria and vascular hypertrophy in spontaneously hypertensive rats on high-salt diet in a blood-pressure-independent manner. Trenkner J; Priem F; Bauer C; Neumayer HH; Raschak M; Hocher B Clin Sci (Lond); 2002 Aug; 103 Suppl 48():385S-388S. PubMed ID: 12193128 [TBL] [Abstract][Full Text] [Related]
9. Antihypertensive effects of a novel endothelin-A receptor antagonist in rats. Bird JE; Moreland S; Waldron TL; Powell JR Hypertension; 1995 Jun; 25(6):1191-5. PubMed ID: 7768562 [TBL] [Abstract][Full Text] [Related]
10. Effects of a selective endothelin A-receptor antagonist, BQ-123, in salt-loaded stroke-prone spontaneously hypertensive rats. Okada M; Kobayashi M; Maruyama H; Takahashi R; Ikemoto F; Yano M; Nishikibe M Clin Exp Pharmacol Physiol; 1995 Oct; 22(10):763-8. PubMed ID: 8575114 [TBL] [Abstract][Full Text] [Related]
11. Renal endothelin ET(A)/ET(B) receptor imbalance differentiates salt-sensitive from salt-resistant spontaneous hypertension. Rothermund L; Luckert S; Kossmehl P; Paul M; Kreutz R Hypertension; 2001 Feb; 37(2):275-80. PubMed ID: 11230285 [TBL] [Abstract][Full Text] [Related]
12. Hemodynamic and biochemical effects of endothelin-A- and -B-receptor antagonist TAK-044 in stroke-prone spontaneously hypertensive rats. Naruse M; Tanabe A; Naruse K; Adachi C; Yoshimoto T; Seki T; Takagi S; Imaki T; Watanabe T; Takano K J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S334-6. PubMed ID: 11078413 [TBL] [Abstract][Full Text] [Related]
13. Nephroprotection of an ET(A)-receptor blocker (LU 135252) in salt-loaded uninephrectomized stroke-prone spontaneously hypertensive rats. Orth SR; Esslinger JP; Amann K; Schwarz U; Raschack M; Ritz E Hypertension; 1998 Apr; 31(4):995-1001. PubMed ID: 9535426 [TBL] [Abstract][Full Text] [Related]
14. Vascular endothelin-1 expression and effect of an endothelin ETA antagonist on structure and function of small arteries from stroke-prone spontaneously hypertensive rats. Sharifi AM; He G; Touyz RM; Schiffrin EL J Cardiovasc Pharmacol; 1998; 31 Suppl 1():S309-12. PubMed ID: 9595467 [TBL] [Abstract][Full Text] [Related]
15. Antihypertensive effects of a mixed endothelin-A- and -B-receptor antagonist, J-104132, were augmented in the presence of an AT1 -receptor antagonist, MK-954. Ikeda T; Ohta H; Okada M; Kawai N; Nakao R; Siegl PK; Kobayashi T; Miyauchi T; Nishikibe M J Cardiovasc Pharmacol; 2000 Nov; 36(5 Suppl 1):S337-41. PubMed ID: 11078414 [TBL] [Abstract][Full Text] [Related]
16. Antihypertensive effect of an endothelin receptor antagonist in DOCA-salt spontaneously hypertensive rats. Schiffrin EL; Sventek P; Li JS; Turgeon A; Reudelhuber T Br J Pharmacol; 1995 Aug; 115(8):1377-81. PubMed ID: 8564194 [TBL] [Abstract][Full Text] [Related]
17. Renal and vascular effects of chronic endothelin receptor antagonism in malignant hypertensive rats. Li JS; Schürch W; Schiffrin EL Am J Hypertens; 1996 Aug; 9(8):803-11. PubMed ID: 8862227 [TBL] [Abstract][Full Text] [Related]